Mereo BioPharma
H120 results and corporate reviewMereo BioPharma
TIGIT programme starts the next chapterMereo BioPharma
Private placement raises $70m (£56m)Mereo BioPharma
Funding deals worth up to $33m announcedMereo BioPharma
Additional ASTEROID data supports progressionMereo BioPharma
Oncologie takes global licence to NaviMereo BioPharma
Underappreciated and undervaluedMereo BioPharma
Setrusumab ready to advance into pivotal studiesMereo BioPharma
Setrusumab set to advanceMereo BioPharma
Entering an important 12 month period